Drug patch definition

Drug patch means an absorbent body perspiration collection patch used to detect the presence of controlled substances, including cocaine, marijuana, amphetamines, methamphetamine, phencyclidine, barbiturates, benzodiazepines, methadone, and opiates, including heroin, morphine, codeine, hydrocodone, and oxycodone.
Sample 1Sample 2Sample 3
Drug patch means any type of device affixed to a person's skin to test for the presence of controlled substances in the person's body.
Sample 1Sample 2Sample 3
Drug patch means any type of device that is affixed to a person’s skin that tests for the presence of a controlled substance, as defined in W.S. § 35-7-1002(a)(iv), in the participant’s body;
Sample 1Sample 2

Examples of Drug patch in a sentence

  • For example, although the complaint’s allegations related primarily to the products BioTherapex and NeuroPlus, Section I of the Judgment prohibits certain representations relating to “any Dietary Supplement, over-the-counter Drug, patch, cream, wrap, or other product worn on the body or rubbed into the skin.” Id. at 6.

  • Drug patch specimens are to be mailed, at a minimum by First Class mail, to the laboratory within twenty-four (24) hours of removal, using mailing packages prepared by PharmChem.

  • When a Narcotic or Controlled Drug patch is removed from a patient, ensure that the patch has a witnessed destruction.

  • Drug patch specimens are to be mailed, at a minimum by First Class mail, to the laboratory within twenty-four (24) hours of removal, using mailing packages prepared by Pharmchem.

  • The 24/7 Sobriety Program currently monitors total abstinence from alcohol and drugs through one or more of the following tests: • Twice a day breath testing (PBTx2),• Electronic alcohol monitoring through the use of ankle bracelet testing,• Drug patch testing; and• Urine testing.

  • Drug patch testing in systemic cutaneous drug allergy.Toxicology 2005; 209: 209–16.

  • However there is one exception to this; in the instance of application of a Controlled Drug patch being delegated to Domiciliary Care Workers, a Community Nurse must go through a checklist for the individual service user with the workers involved as part of the governance arrangements (Appendix 7).

  • Barbaud, A., Drug patch testing in systemic cutaneous drug allergy, Toxicology, 209, 209, 2005.


More Definitions of Drug patch

Drug patch means an absorbent body perspiration collection patch used to detect the metabolite of controlled substances.
Sample 1Sample 2
Drug patch means any type of device affixed to a person’s skin to test for the presence of controlled substances in the person’s body.
Sample 1
Drug patch means an adhesive patch affixed to the skin for a set number of days that uses sweat to detect the parent drug and drug metabolite.
Sample 1
Drug patch means any type of device that is affixed to a
Sample 1

Related to Drug patch

  • Drug Product means a specific drug in dosage form from a known source of manufacture, whether

  • Drug sample means a unit of a prescription drug that is not intended to be sold and is intended to promote the sale of the drug.

  • Drug Substance means an active ingredient that is intended to furnish pharmacological activity or other direct effect in the diagnosis, cure, mitigation, treatment, or prevention of disease or to affect the structure or any function of the human body, but does not include intermediates used in the synthesis of such ingredient.

  • Phase I Clinical Study means, as to a particular Licensed Product, an initial clinical study in humans with the purpose of assessing the Licensed Product’s safety, tolerability, toxicity, pharmacokinetics or other pharmacological properties.

  • Finished Product means a cannabis product in its final form to be sold at a retail premises.

  • API means American Petroleum Institute.

  • Phase I Clinical Trial means a study in humans which provides for the first introduction into humans of a product, conducted in normal volunteers or patients to generate information on product safety, tolerability, pharmacological activity or pharmacokinetics, or otherwise consistent with the requirements of U.S. 21 C.F.R. §312.21(a) or its foreign equivalents.

  • Phase II Clinical Study means a human clinical study of a product initiated to determine the safety and efficacy in the target patient population, as described 21 C.F.R. 312.21(b).

  • Batch means a specific quantity of Product that is intended to have uniform character and quality, within specified limits, and is produced according to a single manufacturing order during the same cycle of manufacture.

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • ANDA means an Abbreviated New Drug Application filed with the FDA pursuant to its rules and regulations.

  • Drug test means a test designed to detect the illegal use of a controlled substance.

  • Phase 1 Clinical Trial means a Clinical Trial of a Product on sufficient numbers of normal volunteers and/or patients that is designed to establish that such Product is safe for its intended use and to support its continued testing in Phase 2 Clinical Trials. For purposes of this Agreement, ‘initiation’ of a Phase 1 Clinical Trial for a Product means the first dosing of such Product in a human subject in a Phase 1 Clinical Trial.

  • Phase II Clinical Trial means a controlled human clinical study that would satisfy the requirements of 21 CFR 312.21(b), conducted to study the effectiveness and establish the dose range of a Product for a particular Indication in patients with the disease or condition under study, including a Phase IIA Clinical Study or Phase IIB Clinical Study.

  • Manufacturing Process means any process for—

  • Aerosol product means a pressurized spray system that dispenses product ingredients by means of a propellant contained in a product or a product's container, or by means of a mechanically induced force. “Aerosol Product” does not include “Pump Spray.”

  • Phase III Clinical Study means a trial involving administration of a Compound to sufficient numbers of human patients with the goal of establishing that the Compound is safe and efficacious for its intended use, to define warnings, precautions and adverse reactions that are associated with the drug or label expansion of such Compound, and to be considered as a pivotal study for submission of an NDA.

  • Phase 4 Clinical Trial means a Clinical Study in any country which is conducted after Regulatory Approval of a product has been obtained from an appropriate Regulatory Authority, consisting of trials conducted voluntarily for enhancing marketing or scientific knowledge of an approved indication and trials conducted due to request or requirement of a Regulatory Authority.

  • Drug Approval Application means, with respect to a Licensed Product in the Territory, an application for Regulatory Approval for such product in a country in the Territory. For purposes of clarity, Drug Approval Application shall include, without limitation, (a) an NDA or BLA (for U.S.) or MAA (for Europe); (b) a counterpart of an NDA, BLA or MAA in any country or region in the Territory; and (c) all supplements (including supplemental applications such as sNDAs) and amendments to the foregoing.

  • Phase IIb Clinical Trial means a clinical trial of a Product on sufficient numbers of patients that is designed to provide a preliminary determination of safety and efficacy of such Product in the target patient population over a range of doses and dose regimens.

  • Licensed Compound means (a) 3,4-Diaminopyridine, the chemical structure of which is set forth on Exhibit B-2; and (b) any derivatives, isomers, metabolites, prodrugs, acid forms, base forms, salt forms, or modified versions of such compound in (a).

  • Investigational Medicinal Product means the study drug or control material as defined in the Protocol.

  • Drug means (i) articles or substances recognized in the official United States Pharmacopoeia

  • Clinical Study means a Phase I Study, Phase II Study, Phase III Study, as applicable.

  • DMF means any drug master file filed with the FDA, and any equivalent filing in other countries or regulatory jurisdictions.

  • Drug Application means a new drug application, an abbreviated drug application, or a product license application for any Product, as appropriate, as those terms are defined in the FDCA.